Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gustafson WC, Meyerowitz JG, Nekritz EA, Chen J, Benes C, Charron E, et al. Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer cell. 2014;26:414–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeid R, Lawlor MA, Poon E, Reyes JM, Fulciniti M, Lopez MA, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018;50:515–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eilers M, Eisenman RN. Myc’s broad reach. Genes Dev. 2008;22:2755–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013;3:a014415.

Article  PubMed  PubMed Central  Google Scholar 

David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463:364–8.

Article  CAS  PubMed  Google Scholar 

Anczuków O, Akerman M, Clery A, Wu J, Shen C, Shirole NH, et al. SRSF1-regulated alternative splicing in breast cancer. Mol cell. 2015;60:105–17.

Article  PubMed  PubMed Central  Google Scholar 

Ladomery M. Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol. 2013;2013:463786.

Zhou Y, Han C, Wang E, Lorch AH, Serafin V, Cho B-K, et al. Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia. Cancer Discov. 2020;10:1388–409.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Marabti E, Younis I. The cancer spliceome: reprograming of alternative splicing in cancer. Front Mol Biosci. 2018;5:80.

Article  PubMed  PubMed Central  Google Scholar 

Jurica MS, Moore MJ. Pre-mRNA splicing: awash in a sea of proteins. Mol cell. 2003;12:5–14.

Article  CAS  PubMed  Google Scholar 

Palacios I, Hetzer M, Adam SA, Mattaj IW. Nuclear import of U snRNPs requires importin β. EMBO J. 1997;16:6783–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Urlaub H, Raker VA, Kostka S, Lührmann R. Sm protein–Sm site RNA interactions within the inner ring of the spliceosomal snRNP core structure. EMBO J. 2001;20:187–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meister G, Eggert C, Bühler D, Brahms H, Kambach C, Fischer U. Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol. 2001;11:1990–4.

Article  CAS  PubMed  Google Scholar 

Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, Van Duyne G, et al. The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol. 2001;21:8289–8300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blijlevens M, van der Meulen-Muileman IH, de Menezes RX, Smit EF, van Beusechem VW. High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome. Oncogene. 2019;38:4142–53.

Article  CAS  PubMed  Google Scholar 

Cunha IW, Carvalho KC, Martins WK, Marques SM, Muto NH, Falzoni R, et al. Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors. Transl Oncol. 2010;3:23–IN25.

Article  PubMed  PubMed Central  Google Scholar 

Blijlevens M, Komor MA, Sciarrillo R, Smit EF, Fijneman RJ, van Beusechem VW. Silencing core spliceosome Sm gene expression induces a cytotoxic splicing switch in the proteasome subunit beta 3 mRNA in non-small cell lung cancer cells. Int J Mol Sci. 2020;21:4192.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koedoot E, van Steijn E, Vermeer M, González-Prieto R, Vertegaal AC, Martens JW, et al. Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention. J Exp Clin Cancer Res. 2021;40:1–17.

Article  Google Scholar 

Siebring-van Olst E, Blijlevens M, de Menezes RX, van der Meulen-Muileman IH, Smit EF, van Beusechem VW. A genome-wide si RNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment. Mol Oncol. 2017;11:534–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weng M-T, Lee J-H, Wei S-C, Li Q, Shahamatdar S, Hsu D, et al. Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells. Proc Natl Acad Sci. 2012;109:E3659–E3667.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tacconelli A, Farina AR, Cappabianca L, DeSantis G, Tessitore A, Vetuschi A, et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer cell. 2004;6:347–60.

Article  CAS  PubMed  Google Scholar 

Guo X, Chen Q-R, Song YK, Wei JS, Khan J. Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status. BMC Med Genom. 2011;4:1–11.

Article  Google Scholar 

Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, et al. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma. Cancer Lett. 2016;371:214–24.

Article  CAS  PubMed  Google Scholar 

Szemes M, Melegh Z, Bellamy J, Park JH, Chen B, Greenhough A, et al. Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms’ tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities. Cancers. 2021;13:656.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong M, He J, Li S. SNW1 regulates Notch signaling in neuroblastoma through interacting with RBPJ. Biochem Biophys Res Commun. 2019;509:869–76.

Article  CAS  PubMed  Google Scholar 

Escobar-Hoyos LF, Penson A, Kannan R, Cho H, Pan C-H, Singh RK, et al. Altered RNA splicing by mutant p53 activates oncogenic RAS signaling in pancreatic cancer. Cancer Cell. 2020;38:198–211.e198.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh CM, Bezzi M, Low DH, Ang WX, Teo SX, Gay FP, et al. MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis. Nature. 2015;523:96–100.

Article  CAS  PubMed  Google Scholar 

Ooi CY, Carter DR, Liu B, Mayoh C, Beckers A, Lalwani A, et al. Network modeling of microRNA–mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN. Cancer Res. 2018;78:3122–34.

Article  CAS  PubMed  Google Scholar 

Hansford LM, Thomas WD, Keating JM, Burkhart CA, Peaston AE, Norris MD, et al. Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification. Proc Natl Acad Sci. 2004;101:12664–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsu TY-T, Simon LM, Neill NJ, Marcotte R, Sayad A, Bland CS, et al. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature. 2015;525:384–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li YI, Knowles DA, Humphrey J, Barbeira AN, Dickinson SP, Im HK, et al. Annotation-free quantification of RNA splicing using LeafCutter. Nat Genet. 2018;50:151–8.

Article  CAS  PubMed  Google Scholar 

Shen S, Park JW, Lu Z-X, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci. 2014;111:E5593–E5601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu T, Millar H, Gaffney D, Beke L, Mannens G, Vinken P, et al. JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer models. Cancer Res. 2018;78 (13_Supplement): 4859. https://doi.org/10.1158/1538-7445.AM2018-4859.

Venables JP. Unbalanced alternative splicing and its significance in cancer. Bioessays. 2006;28:378–86.

Article  CAS  PubMed  Google Scholar 

Bonnal SC, López-Oreja I, Valcárcel J. Roles and mechanisms of alternative splicing in cancer—implications for care. Nat Rev Clin Oncol. 2020;17:457–74.

Article  PubMed  Google Scholar